Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity
Moreira, D., Sampath, S., Won, H., White, S. V., Su, Y. L., Alcantara, M., Wang, C., Lee, P., Maghami, E., Massarelli, E., & Kortylewski, M. (2021). Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. The Journal of clinical investigation, 131(2), e137001. https://doi.org/10.1172/JCI137001